199 related articles for article (PubMed ID: 33098668)
1. Human CXCR5
Hofland T; Martens AWJ; van Bruggen JAC; de Boer R; Schetters S; Remmerswaal EBM; Bemelman FJ; Levin MD; Bins AD; Eldering E; Kater AP; Tonino SH
Eur J Immunol; 2021 Mar; 51(3):703-713. PubMed ID: 33098668
[TBL] [Abstract][Full Text] [Related]
2. CXCR5
Zhou Y; Guo L; Sun H; Xu J; Ba T
Int Immunopharmacol; 2018 Sep; 62():114-119. PubMed ID: 30005226
[TBL] [Abstract][Full Text] [Related]
3. Programmed death 1 expressing CD8
Khanam A; Tang LSY; Kottilil S
Hepatology; 2022 Mar; 75(3):690-708. PubMed ID: 34689344
[TBL] [Abstract][Full Text] [Related]
4. Characterization of CXCR5
Perdomo-Celis F; Medina-Moreno S; Davis H; Bryant J; Taborda NA; Rugeles MT; Kottilil S; Zapata JC
Immunobiology; 2020 Mar; 225(2):151885. PubMed ID: 31836302
[TBL] [Abstract][Full Text] [Related]
5. PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection.
Im SJ; Konieczny BT; Hudson WH; Masopust D; Ahmed R
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4292-4299. PubMed ID: 32034098
[TBL] [Abstract][Full Text] [Related]
6. A Subset of CXCR5
Shen J; Luo X; Wu Q; Huang J; Xiao G; Wang L; Yang B; Li H; Wu C
Front Immunol; 2018; 9():2287. PubMed ID: 30344522
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of PD-1 blockade in cervical cancer is related to a CD8
Heeren AM; Rotman J; Stam AGM; Pocorni N; Gassama AA; Samuels S; Bleeker MCG; Mom CH; Zijlmans HJMAA; Kenter GG; Jordanova ES; de Gruijl TD
J Immunother Cancer; 2019 Feb; 7(1):43. PubMed ID: 30755279
[TBL] [Abstract][Full Text] [Related]
8. CXCR5
Xing J; Zhang C; Yang X; Wang S; Wang Z; Li X; Yu E
Exp Cell Res; 2017 Jul; 356(1):57-63. PubMed ID: 28412245
[TBL] [Abstract][Full Text] [Related]
9. Induction of Follicular-Like CXCR5
Perdomo-Celis F; Feria MG; Taborda NA; Rugeles MT
Viral Immunol; 2019 Sep; 32(7):278-288. PubMed ID: 31274389
[TBL] [Abstract][Full Text] [Related]
10. TCR Repertoire Diversity of Peripheral PD-1
Han J; Duan J; Bai H; Wang Y; Wan R; Wang X; Chen S; Tian Y; Wang D; Fei K; Yao Z; Wang S; Lu Z; Wang Z; Wang J
Cancer Immunol Res; 2020 Jan; 8(1):146-154. PubMed ID: 31719056
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral Tcf1
Siddiqui I; Schaeuble K; Chennupati V; Fuertes Marraco SA; Calderon-Copete S; Pais Ferreira D; Carmona SJ; Scarpellino L; Gfeller D; Pradervand S; Luther SA; Speiser DE; Held W
Immunity; 2019 Jan; 50(1):195-211.e10. PubMed ID: 30635237
[TBL] [Abstract][Full Text] [Related]
12. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.
Yang M; Lu J; Zhang G; Wang Y; He M; Xu Q; Xu C; Liu H
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452206
[TBL] [Abstract][Full Text] [Related]
13. CD8
Huang B; Liu R; Wang P; Yuan Z; Yang J; Xiong H; Zhang N; Huang Q; Fu X; Sun W; Li L
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32606053
[TBL] [Abstract][Full Text] [Related]
14. Follicular CD8+ T Cells Are Elevated in HIV Infection and Induce PD-L1 on B Cells.
MartÃnez LE; Ibarrondo J; Guo Y; Penichet ML; Epeldegui M
J Immunol; 2023 Jan; 210(1):33-39. PubMed ID: 36445393
[TBL] [Abstract][Full Text] [Related]
15. Follicular helper T cells promote the effector functions of CD8
Shi W; Dong L; Sun Q; Ding H; Meng J; Dai G
Exp Cell Res; 2018 Nov; 372(1):35-42. PubMed ID: 30205088
[TBL] [Abstract][Full Text] [Related]
16. PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy.
Simon S; Voillet V; Vignard V; Wu Z; Dabrowski C; Jouand N; Beauvais T; Khammari A; Braudeau C; Josien R; Adotevi O; Laheurte C; Aubin F; Nardin C; Rulli S; Gottardo R; Ramchurren N; Cheever M; Fling SP; Church CD; Nghiem P; Dreno B; Riddell SR; Labarriere N
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188038
[TBL] [Abstract][Full Text] [Related]
17. CXCR5
Jin Y; Lang C; Tang J; Geng J; Song HK; Sun Z; Wang J
Int Immunopharmacol; 2017 Dec; 53():42-48. PubMed ID: 29032029
[TBL] [Abstract][Full Text] [Related]
18. Increased CCR7
Huang YX; Zhao QY; Wu LL; Xie DY; Gao ZL; Deng H
Can J Gastroenterol Hepatol; 2018; 2018():1020925. PubMed ID: 30402448
[TBL] [Abstract][Full Text] [Related]
19. Increased Coexpression of PD-1, TIGIT, and KLRG-1 on Tumor-Reactive CD8
Hutten TJA; Norde WJ; Woestenenk R; Wang RC; Maas F; Kester M; Falkenburg JHF; Berglund S; Luznik L; Jansen JH; Schaap N; Dolstra H; Hobo W
Biol Blood Marrow Transplant; 2018 Apr; 24(4):666-677. PubMed ID: 29197680
[TBL] [Abstract][Full Text] [Related]
20. CXCR5
Bai M; Zheng Y; Liu H; Su B; Zhan Y; He H
Exp Cell Res; 2017 Dec; 361(1):39-45. PubMed ID: 28965867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
